Compounds for the Treatment of Hepatitis C
AssigneeBristol-Myers Squibb Company
InventorsKap-Sun Yeung, Kyle E. Parcella, John A. Bender, Brett R. Beno, Katharine A. Grant-Young, Ying Han, Piyasena Hewawasam, John F. Kadow, Andrew Nickel
Life of this patent
Estimating the term…
Abstract
The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
Claims2
A method of treating hepatitis C infection comprising administering to a patient a therapeutically effective amount of the compound 4-Fluoro-2-(4-fluorophenyl)-N-methyl-5-(2-methyl-5-(1-(pyrimidin-2-yl)cyclopropylcarbamoyl)phenyl)benzofuran-3-carboxamide or a pharmaceutically acceptable salt thereof
- in conjunction with (prior to, after, or concurrently) an interferon.
Dependencies are inferred from the claim text.